DR. JAYASEELAN AMBROSE, M.D.

Plain English
This study looked at how long it takes for patients with epilepsy to be evaluated at specialized centers within a healthcare system in Northern California. On average, patients waited about 3.9 years after starting anti-seizure medications and 3.2 years after their epilepsy diagnosis to see a specialist. This is important because faster access to specialized care can lead to better treatment options and outcomes for patients. Who this helps: This helps patients with epilepsy and their healthcare providers.

Plain English
This study looked at a protein called CXCL5 that cancer cells produce, which helps them evade the immune system, particularly in obese mice with pancreatic cancer. Researchers found that reducing CXCL5 levels led to more immune cells, especially T cells, getting into the tumors and significantly decreased tumor size when combined with anti-PD-1 therapy. This matters because it shows that targeting CXCL5 could make cancer treatments more effective, especially for obese patients. Who this helps: This helps patients with pancreatic cancer, particularly those who are obese.

Plain English
This research looked at how well genetic testing for cancer represents people from different ethnic backgrounds in the UK. The study found that while Black women with breast cancer were better represented in the 100,000 Genomes Project compared to national averages (with a recruitment rate ratio of 2.2), Black and South Asian patients had more instances of certain gene variants linked to cancer but fewer actionable mutations compared to European patients. This matters because it shows the need for better processes in genetic testing to ensure fair access and treatment for everyone, regardless of their background. Who this helps: This helps cancer patients from diverse ethnic backgrounds.

Plain English
This study looked at 1,283 adults in the U.S. with chronic lymphocytic leukemia (CLL) who received at least two different treatments between 2014 and 2022. It found that 42% of these patients went on to receive a third treatment, but over 18% died before starting it, and more than a quarter died before a fourth treatment. These findings highlight ongoing challenges for patients needing multiple therapies, despite improvements in treatment options over the years. Who this helps: This benefits patients with CLL, particularly those who require multiple lines of therapy.

Plain English
This study examined the genomes of breast cancer patients in the UK to see if genetic data could help predict who might face an early death from the disease. Among nearly 2,450 breast cancer tumors analyzed, researchers found that about 27% had genetic features that could inform personalized treatment, such as unique mutations or vulnerabilities to specific therapies. This research is important because it may lead to more tailored treatment plans that can better address the risks faced by individual patients. Who this helps: This benefits breast cancer patients by guiding more specific treatment options based on their unique genetic profiles.

Plain English
This study looked at how well a new way of tracking patient deaths matched up with the official death records for people with certain blood cancers in the U.S. They checked the data from over 21,500 patients and found that the new tracking method was very accurate, with an 88% match in exact death dates and high sensitivity (87.8%) and specificity (95.7%). This matters because improving how we record and understand patient outcomes can lead to better research and care for patients with cancer. Who this helps: Patients and doctors treating blood cancers.

Plain English
This study looked at how much COVID-19 has cost active duty U.S. Army soldiers, both in terms of medical care and lost work time. On average, the direct medical costs for soldiers diagnosed with COVID-19 were about $606 each, but the costs related to lost duty time were much higher, averaging around $4,331 per soldier. This information is crucial for the Army to understand the financial impact of COVID-19 on its service members and helps with planning for future healthcare needs. Who this helps: This benefits the U.S. Army and military healthcare planners.

Plain English
This study looked at genomic data from 13,880 tumors across 33 types of cancer to see how it could improve cancer treatment in the UK. They found that certain genetic mutations occurred at different rates in various cancers; for example, 94% of glioblastoma cases had small mutations, while 40% of high-grade serous ovarian cancer cases had specific deficiencies related to inherited genes. These insights help doctors better understand which genetic factors influence treatment success and survival, leading to more personalized cancer care. Who this helps: This benefits cancer patients and their doctors by guiding more effective, tailored treatment options.

Plain English
This study looked at three treatment combinations using the drug daratumumab in patients with relapsed or refractory multiple myeloma. Researchers analyzed data from 639 patients and found that the treatment regimens dara-Kd (carfilzomib) and dara-Pd (pomalidomide) offered longer times before patients needed to switch treatments compared to dara-Vd (bortezomib). Specifically, patients on dara-Kd had a median time of 12.9 months and those on dara-Pd had 15.3 months, while those on dara-Vd had only 7.6 months, indicating that dara-Vd may not be the best option for future clinical trials. Who this helps: This information benefits doctors and patients choosing treatment options for relapsed multiple myeloma.

Plain English
This study looked at how having family members living in cities affects the survival of rural patients with genitourinary cancers. Researchers found that rural patients without urban relatives had a 33% higher risk of dying from cancer in 5 years, and 46% higher in 10 years, compared to urban patients. In contrast, rural patients with urban relatives had a better survival rate, with a 21% lower risk of dying in 5 years and 16% lower in 10 years compared to rural patients without urban family. This is important because it highlights how access to urban family support can lead to better cancer outcomes for people living in rural areas. Who this helps: This helps rural cancer patients and their families.

Plain English
This study examined how the area where doctors practice affects the likelihood of providing unnecessary cancer screenings, like mammograms and PSA tests, to patients aged 75 and older. It found that doctors who moved from areas with high rates of unnecessary screenings to those with lower rates tended to provide less unnecessary care. For instance, doctors relocating from high-rate areas offered a 6.0% rate of low-value mammograms compared to 10.1% among their peers who stayed in high-rate areas. This matters because it shows that the environment and practices of a medical community can influence care quality and patients’ health outcomes. Who this helps: This helps patients, particularly older adults who may be receiving unnecessary cancer screenings.

Plain English
This study looked at how a family member's diagnosis of genitourinary cancer affects the mental and heart health of their first-degree relatives and spouses. It found that within one year of a loved one being diagnosed, there was a 10% higher chance of these relatives developing psychological issues and a 28% higher chance of experiencing cardiovascular problems. This matters because it highlights the significant emotional and physical stress that cancer causes not only to patients but also to their families, indicating a need for better support systems for them. Who this helps: This helps family members of cancer patients by showing the importance of mental health and heart health support.

Plain English
This study looked at how the U.S. Army tracked COVID-19 cases among its service members and their families during the first year of the pandemic. They reported 96,315 cases, with 99% confirmed and a low hospitalization rate of just 2.4%, while only 0.3% of those infected died. These findings highlight the importance of having strong health monitoring systems in place to help Army leaders make informed decisions regarding their members' health and safety. Who this helps: This helps patients and military leadership in the U.S. Army.

Plain English
This study looked at how a protein called SHP2 affects fat cells and their interaction with pancreatic cancer cells. Researchers found that high levels of phospho-SHP2 in fat tissue from obese people and mice helped maintain fat cell health but also promoted the secretion of IL-6, a substance that can fuel cancer growth. By blocking SHP2 or related proteins, they noticed fat cells released less IL-6 and that pancreatic cancer cells grew slower when exposed to these altered fat cell signals. Who this helps: This benefits patients, particularly those with obesity and pancreatic cancer.

Plain English
This study looked at how to help adults with hearing loss through a process called aural rehabilitation (AR), which includes strategies like counseling and training to improve their hearing abilities. The researchers reviewed 85 studies and created guidelines to help healthcare providers make better decisions when treating patients with hearing loss. The goal is to ensure that patients receive effective care, which can lead to better health outcomes and quality of life. Who this helps: This helps adults with hearing loss and the healthcare professionals who support them.

Plain English
Researchers looked at how primary care doctors feel about using electronic tools to help them decide when to order prostate cancer tests based on PSA levels. Out of 201 surveyed doctors, 29% responded, and all of them showed interest in using these tools, regardless of how often they currently order PSA tests. This is important because having evidence-based support could improve test ordering practices and ensure better patient care while addressing concerns about doctors' decision-making autonomy. Who this helps: This helps doctors and their male patients aged 40 to 80 years.

Plain English
This research investigated how the fat surrounding the pancreas (adipose tissue) influences pancreatic cancer (PDAC) by affecting immune responses. The study found that fat-derived signals like IL-1β and TNF increase the levels of a protein called CXCL5 in cancer cells, blocking immune cells from attacking tumors. When CXCL5 was removed from tumors in obese mice, the tumors shrank, showing that targeting this protein could help improve treatment outcomes for obese patients with pancreatic cancer. Who this helps: This research benefits patients with pancreatic cancer, particularly those who are obese.

Plain English
In a study of U.S. Army basic training installations in 2022, researchers identified 254 cases of acute respiratory disease (ARD) among trainees, but there were no major outbreaks. Including other cases without fever revealed an additional 1,696 possible ARD cases, yet still no installations met the criteria for an outbreak, continuing a three-year trend without reported outbreaks. This is important because preventing ARD outbreaks helps maintain the health and readiness of Army trainees who live and train in close quarters, which is crucial for military operations. Who this helps: This helps military trainees and healthcare providers working to keep them healthy.

Plain English
This study looked at how certain inhibitors that target the BRG1 and BRM proteins affect acute myeloid leukemia (AML) cells. The researchers found that leukemia cell lines were highly sensitive to these inhibitors, with significant effects on cancer-related gene expression. Notably, they observed that these inhibitors reduced activity of important cancer genes like MYC, suggesting that targeting these proteins could be an effective treatment strategy for leukemia. Who this helps: This benefits patients with acute myeloid leukemia and their doctors by providing potential new treatment options.

Plain English
This study looked at how a synthetic drug called AdipoRon affects the metabolism of pancreatic cancer cells. Researchers found that when these cancer cells were treated with AdipoRon, they used more glucose and became reliant on this sugar for energy instead of their usual method involving mitochondria. This shift is important because it shows how pancreatic cancer cells can adapt to survive when their normal energy production is disrupted, which could help in developing more effective treatments. Who this helps: This helps patients with pancreatic cancer by providing insights that may lead to better therapies.

Plain English
This study looked at five different commercial platforms for analyzing DNA methylation, a process that can affect gene expression. Researchers tested these platforms on 11 samples and found that although all provided strong results, there were significant differences in the specific DNA sites they covered, making comparisons hard. By using a technique called imputation, they improved the overlap of data between platforms from about 10% to 97%, enabling better integration of results across different systems, which helps scientists make more accurate comparisons. Who this helps: This benefits researchers and clinicians working in genetics and personalized medicine.

Plain English
This study examined a new cancer drug called LXH254, which targets specific proteins involved in certain tumors. Researchers found that LXH254 effectively inhibited two proteins, BRAF and CRAF, but had less effect on another protein called ARAF. The drug was particularly effective in cancer cell models with changes in BRAF, leading to complete tumor shrinkage in some cases, especially when ARAF was not present. Who this helps: This benefits patients with RAS-mutant tumors, particularly those with BRAF-related changes.

Plain English
This study looked at how certain natural compounds, called limonoids, can fight melanoma, specifically types with specific genetic mutations (BRAF and NRAS). Researchers found that these compounds work by targeting a gene called CYP27A1, which affects how the cancer cells produce energy. By interfering with this energy production process, the limonoids can inhibit the growth of melanoma cells, showing promise for targeted treatments against this skin cancer. Who this helps: Patients with BRAF or NRAS-mutant melanoma.

Plain English
This study looked at how effective an F-fluciclovine PET scan is for detecting recurring prostate cancer in men who have already received treatment, focusing on different levels of Prostate-Specific Antigen (PSA). They found that as PSA levels increased, the detection rates of cancer also increased: only 55.5% of men with PSA levels below 0.5 had positive scans, while 91.5% of men with PSA levels over 2 did. This information is important because it helps determine the best PSA threshold for using these scans to catch cancer recurrences earlier and ensure men receive timely treatment. Who this helps: This helps patients at risk of prostate cancer recurrence and their doctors.

Plain English
This study looked at how where people lived in their early years might affect their risk of getting cancer later in life. Researchers followed nearly 260,600 individuals from the 1940 Census and found that 66,904 (about 26%) developed cancer over an average of nearly 51 years. They identified 15 areas where people faced higher risks for various cancers, showing that neighborhoods can influence health outcomes. Who this helps: This helps patients and public health officials understand how early-life environments may impact long-term health.

Plain English
This study looked at how a type of RNA, called G-tract RNA, helps remove a group of proteins known as PRC2 from certain genes in human and mouse cells. The researchers found that when genes are activated, G-tract RNA can effectively push PRC2 away from these genes, leading to important changes in gene expression. Specifically, targeting G-tract RNA to a tumor-suppressing gene called CDKN2A in cancer cells managed to reactivate that gene, which then caused the cancer cells to stop growing. Who this helps: This research benefits cancer patients and doctors by providing new insights into how to reactivate crucial tumor suppressor genes.

Plain English
This paper discusses a discovery about G-tract RNA, which plays a role in removing a group of proteins called Polycomb repressive complex 2 from certain genes. The researchers found that this action helps make genes more active, which is important for cell function. Understanding how this process works can lead to better insights into gene regulation and its implications for health. Who this helps: This helps researchers and doctors working on gene-related diseases.

Plain English
This study explored a new type of material made from clay nanotubes and silicone to prevent bacteria from sticking to medical devices, which can lead to infections. The researchers found that this new material was better at stopping bacterial growth than standard urinary catheters, showing that it could significantly reduce the chances of infection in patients. This is important because it could lead to shorter hospital stays and better patient outcomes. Who this helps: This helps patients who need invasive medical devices, as well as healthcare providers aiming to reduce infection rates.

Plain English
Researchers studied how to improve treatment for multiple myeloma by analyzing genetic data from newly diagnosed patients. They developed a 7-gene test that helped predict which patients would respond better to certain therapies, showing that those treated based on the test had better outcomes—20.1 months of progression-free survival compared to an unmatched group. This matters because it could lead to more personalized and effective treatments for patients, even using existing medications. Who this helps: This helps patients with multiple myeloma by guiding doctors in choosing the best treatment options.

Plain English
This study looked at the costs and benefits of using two blood thinners: enoxaparin and unfractionated heparin (UFH) in a hospital setting. Researchers found that enoxaparin, when used for treating conditions, costs about $30.66 per day compared to $162.30 for UFH; however, both drugs had similar rates of needing follow-up tests for a side effect called heparin-induced thrombocytopenia (HIT), specifically with fewer HIT tests ordered for enoxaparin used as a treatment (0.118 times as often as UFH). These findings matter because they show that using enoxaparin can lead to significant savings when treating patients, but not when using it for prevention. Who this helps: This helps hospitals and patients who require anticoagulation therapy by potentially reducing treatment costs.

Plain English
Researchers studied how melanoma cells form clusters in a special 3D environment, similar to how tumors develop in the body. They found that melanoma cells clumped together much faster than breast cancer cells and created unique structures, such as long, flat aggregates. Importantly, using specific antibodies, they discovered that two of them could stop this clumping, which helps in understanding how to hinder tumor growth. Who this helps: This benefits patients with melanoma and doctors looking for effective treatment options.

Plain English
This research studied how a protein called T-bet influences certain genes in immune cells known as Th1 cells. The study found that T-bet helps activate specific genes by recruiting other proteins that enhance gene activity, which is critical for Th1 cell function. Specifically, blocking these processes stopped the activation of T-bet target genes and prevented certain immune responses, showing that T-bet is essential for Th1 cell differentiation. Who this helps: This helps doctors and researchers working on autoimmune diseases.

Plain English
Researchers created a new computer system that helps study cancer cells in a 3D environment. Their findings showed that certain cancer cells group together quickly, forming complex structures, which was not seen in non-cancer cells. Specifically, they identified new types of cells called "facilitators," "probes," and "dervishes" involved in this process, revealing important details about how tumors develop and how drugs might work against them. Who this helps: This benefits cancer researchers and doctors looking for better treatment strategies.

Plain English
In this study, researchers looked at how cancerous and non-cancerous cells interact in a lab setting. They found that just 5% of cancerous cells can connect and merge clusters of mostly non-cancerous cells by forming special structures called cellular cables. This discovery helps explain why tumors often contain a large number of non-cancerous cells, which is important for understanding tumor behavior and developing new treatments. Who this helps: This helps doctors and researchers working on cancer treatment and understanding tumor dynamics.

Plain English
Researchers studied an outbreak of Legionnaires' disease and Pontiac fever at a military base, finding 29 confirmed cases of Legionnaires' disease and 38 cases of Pontiac fever. The source of the outbreak was linked to airborne bacteria from a cooling tower, where people living in the closest building were significantly more likely to get sick—nearly 7 times more likely for Legionnaires' disease and over 5 times for Pontiac fever compared to those in a nearby building. This finding highlights the importance of identifying and controlling environmental sources of infection to prevent similar outbreaks in the future. Who this helps: This helps military personnel and public health officials.

Plain English
This study measured different forms of mercury in the air to see how well various instruments worked together. Researchers found that some new methods showed levels of reactive mercury up to three times higher than traditional systems, suggesting that reactions were happening in the equipment itself. Understanding these differences helps improve how we monitor mercury in the atmosphere, which is important for environmental health. Who this helps: This helps scientists and environmental policymakers.

Plain English
This study examined the genetics of Usher syndrome, a condition that causes both hearing loss and vision problems, in 172 patients in the UK. The researchers sequenced nine genes related to Usher syndrome and found that most harmful changes were in the MYO7A and USH2A genes, accounting for over 53% and 79% of specific types of the condition, respectively. Importantly, the study found no significant evidence of digenic inheritance, which means that having mutations in two different genes does not frequently contribute to the disease. Who this helps: This research helps patients and doctors by providing clearer information on the genetic causes of Usher syndrome.

Plain English
This study looked at how the drug esomeprazole, which reduces stomach acid, affects chest pain in patients with coronary artery disease. Researchers found that only 24.4% of patients taking esomeprazole experienced chest pain compared to 54.8% of those taking a placebo. This is important because it indicates that esomeprazole can significantly lower chest pain episodes and reduce the need for doctor visits. Who this helps: Patients with coronary artery disease suffering from atypical chest pain.

Plain English
Researchers studied the types of bacteria and archaea living in the soil of the Pine Barrens Forest on Long Island, NY, focusing on how these microorganisms adapt to tough environmental conditions. They collected soil samples from different depths and found that the community of microbes varies significantly at each layer. Notably, they found that a large portion of these microorganisms helps with the nitrogen cycle, with specific bacteria and archaea, such as Nitrosovibrio and Nitrosocaldus, being responsible for converting ammonia, which is important for soil health. Who this helps: This research benefits environmental scientists and ecologists studying soil health and microbial ecosystems.

Plain English
This study examined a 42-year-old woman who experienced sudden heart problems linked to her use of methamphetamine. Researchers found that the woman's left ventricle, a key part of the heart that pumps blood, was temporarily not functioning properly. This situation is similar to other cases where emotional stress affects heart function, but it's important because it's the first time this has been connected to methamphetamine use. Who this helps: This benefits doctors treating patients with heart issues related to drug use.

Plain English
This study looked at the health of adults three months after they were injured and hospitalized. Researchers found that out of 339 patients, those injured reported much lower quality of life scores—meaning they felt worse in many aspects compared to the average Australian, indicating a significant drop in well-being. This matters because it highlights the need for ongoing support and treatment for injured patients to help them recover better. Who this helps: This helps injured patients and healthcare providers who support their recovery.

Plain English
This study looked at whether the drug pioglitazone could help improve blood vessel function in non-diabetic patients with coronary artery disease. The researchers found that after taking pioglitazone for 12 weeks, the patients showed a significant improvement in blood vessel widening, going from an average of 4.4% to 8.4%, which is nearly double. However, after stopping the medication, their blood vessel function returned to previous levels. Who this helps: This helps patients with coronary artery disease.

Plain English
This study looked at a treatment for a blocked vein graft in the heart using a device called the Proxis Embolic Protection System. They found that this system successfully cleared the blockage, improving blood flow rated at 100% after treatment. This is significant because such blockages can lead to serious complications, including heart attacks and increased risk of death. Who this helps: This benefits patients with heart conditions who have undergone previous surgeries and face complications from blocked grafts.

Plain English
This study examined the relationship between specific geometric features of coronary artery blockages and ultrasound signs that indicate the risk of plaque ruptures, which can lead to heart attacks. Researchers looked at 31 lesions in 30 patients with stable heart conditions and found that factors like lesion length and symmetry did not connect to ultrasound markers of plaque vulnerability. This matters because understanding these correlations can help predict heart attack risks, but the findings indicate that these geometric features might not be useful for assessing plaque danger. Who this helps: This helps doctors in evaluating heart disease patients.